Winsunny Pharma’s FY101 Gains NMPA Clinical Approval for Hyperlipidemia
China-based Beijing Winsunny Pharmaceutical Co., Ltd (SHA: 601089) announced that it has received clinical approval...
China-based Beijing Winsunny Pharmaceutical Co., Ltd (SHA: 601089) announced that it has received clinical approval...
Sichuan Gowell Pharmaceutical Co., Ltd. has secured a favorable final judgment in its appeal against...